An Algorithm Measuring Donor Cell-Free DNA in Plasma of Cellular and Solid Organ Transplant Recipients That Does Not Require Donor or Recipient Genotyping

Frontiers in Cardiovascular Medicine

Volumn 3, Issue , 2016, Pages

  Gordon, Paul M K ^a   Khan, Aneal ^a   Sajid, Umair ^a   Chang, Nicholas ^a   Suresh, Varun ^a   Dimnik, Leo ^b   Lamont, Ryan E ^a,b   Parboosingh, Jillian S ^a,b   Martin, Steven R ^a   Pon, Richard T ^a,c   Weatherhead, Jene ^a   Wegener, Shelly ^a   Isaac, Debra ^a   Greenway, Steven C ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

biomarker; cell free DNA; heart; hepatocyte transplantation; solid organ transplantation; transplantation

Indexed keywords

EID: 85018318361     PISSN: None     EISSN: 2297055X     Source Type: Journal    
DOI: 10.3389/fcvm.2016.00033     Document Type: Article

References (30)

1. McMinn JF, Lang NN, McPhadden A, Payne JR, Petrie MC, Gardner RS. Biomarkers of acute rejection following cardiac transplantation. Biomark Med (2014) 8(6):815–32.10.2217/bmm.14.5625224938
2. Meyburg J, Das AM, Hoerster F, Lindner M, Kriegbaum H, Engelmann G, et al. One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defects. Transplantation (2009) 87(5):636–41.10.1097/TP.0b013e318199936a19295306
3. Yudkoff M, Daikhin Y, Ye X, Wilson JM, Batshaw ML. In vivo measurement of ureagenesis with stable isotopes. J Inherit Metab Dis (1998) 21(Suppl 1):21–9.10.1023/A:10053452054039686342
4. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology (2007) 39(2):197–207.10.1080/0031302070123083117454749
5. Lo YM, Chiu RW. Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications. J Pathol (2011) 225(3):318–23.10.1002/path.296021984122
6. Mouliere F, Rosenfeld N. Circulating tumor-derived DNA is shorter than somatic DNA in plasma. Proc Natl Acad Sci U S A (2015) 112(11):3178–9.10.1073/pnas.1501321112
7. De Vlaminck I, Valantine HA, Snyder TM, Strehl C, Cohen G, Luikart H, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med (2014) 6(241):241ra77.10.1126/scitranslmed.300780324944192
8. Beck J, Bierau S, Balzer S, Andag R, Kanzow P, Schmitz J, et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem (2013) 59(12):1732–41.10.1373/clinchem.2013.21032824061615
9. Snyder TM, Khush KK, Valantine HA, Quake SR. Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci U S A (2011) 108(15):6229–34.10.1073/pnas.101392410821444804
10. Sigdel TK, Vitalone MJ, Tran TQ, Dai H, Hsieh SC, Salvatierra O, et al. A rapid noninvasive assay for the detection of renal transplant injury. Transplantation (2013) 96(1):97–101.10.1097/TP.0b013e318295ee5a23756769
11. Hidestrand M, Tomita-Mitchell A, Hidestrand PM, Oliphant A, Goetsch M, Stamm K, et al. Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid. J Am Coll Cardiol (2014) 63(12):1224–6.10.1016/j.jacc.2013.09.029
12. Macher HC, Suarez-Artacho G, Guerrero JM, Gomez-Bravo MA, Alvarez-Gomez S, Bernal-Bellido C, et al. Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor. PLoS One (2014) 9(12):e113987.10.1371/journal.pone.011398725489845
13. Adamek M, Opelz G, Klein K, Morath C, Tran TH. A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function. (2016) 54(7):1147–55.10.1515/cclm-2015-0622
14. Beck J, Oellerich M, Schulz U, Schauerte V, Reinhard L, Fuchs U, et al. Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation. Transplant Proc (2015) 47(8):2400–3.10.1016/j.transproceed.2015.08.035
15. Berry GJ, Burke MM, Andersen C, Bruneval P, Fedrigo M, Fishbein MC, et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2013) 32(12):1147–62.10.1016/j.healun.2013.08.01124263017
16. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. The J Heart Lung Transplant (2005) 24(11):1710–20.10.1016/j.healun.2005.03.019
17. Pakstis AJ, Speed WC, Fang R, Hyland FC, Furtado MR, Kidd JR, et al. SNPs for a universal individual identification panel. Hum Genet (2010) 127(3):315–24.10.1007/s00439-009-0771-119937056
18. Sanchez JJ, Phillips C, Borsting C, Balogh K, Bogus M, Fondevila M, et al. A multiplex assay with 52 single nucleotide polymorphisms for human identification. Electrophoresis (2006) 27(9):1713–24.10.1002/elps.20050067116586411
19. Karafet TM, Mendez FL, Meilerman MB, Underhill PA, Zegura SL, Hammer MF. New binary polymorphisms reshape and increase resolution of the human Y chromosomal haplogroup tree. Genome Res (2008) 18(5):830–8.10.1101/gr.717200818385274
20. Benaglia T, Chauveau D, Hunter DR, Young DS. mixtools: an R package for analyzing mixture mod. J Stat Softw (2009) 32(6):1–29.10.18637/jss.v032.i06
21. De Vlaminck I, Martin L, Kertesz M, Patel K, Kowarsky M, Strehl C, et al. Noninvasive monitoring of infection and rejection after lung transplantation. Proc Natl Acad Sci U S A (2015) 112(43):13336–41.10.1073/pnas.151749411226460048
22. Kohlova M, Ribeiro S, do Sameiro-Faria M, Rocha-Pereira P, Fernandes J, Reis F, et al. Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses. Hemodial Int (2013) 17(4):664–7.10.1111/hdi.12055
23. Yamashita AC, Sakurai K. Clinical effect of pre-dilution hemodiafiltration based on the permeation of the hemodiafilter. Contrib Nephrol (2015) 185:1–7.10.1159/00038096426023009
24. Krishna Vanaja D, Sivakumar B, Jesudasan RA, Singh L, Janardanasarma MK, Habibullah CM. In vivo identification, survival, and functional efficacy of transplanted hepatocytes in acute liver failure mice model by FISH using Y-chromosome probe. Cell Transplant (1998) 7(3):267–73.10.1016/S0963-6897(98)00004-99647436
25. Bilir BM, Guinette D, Karrer F, Kumpe DA, Krysl J, Stephens J, et al. Hepatocyte transplantation in acute liver failure. Liver Transpl (2000) 6(1):32–40.10.1002/lt.50006011310648575
26. Breitbach S, Tug S, Simon P. Circulating cell-free DNA: an up-coming molecular marker in exercise physiology. Sports Med (2012) 42(7):565–86.10.2165/11631380-000000000-0000022694348
27. Dwivedi DJ, Toltl LJ, Swystun LL, Pogue J, Liaw KL, Weitz JI, et al. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care (2012) 16(4):R151.10.1186/cc1146622889177
28. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem (2000) 46(3):319–23.10702517
29. Gielis EM, Ledeganck KJ, De Winter BY, Del Favero J, Bosmans JL, Claas FH, et al. Cell-free DNA: an upcoming biomarker in transplantation. Am J Transplant (2015) 15(10):2541–51.10.1111/ajt.1338726184824
30. De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell (2013) 155(5):1178–87.10.1016/j.cell.2013.10.03424267896